Tag: Pf Magazine January 2019
Latest articles
MHRA approves second monoclonal antibody COVID-19 treatment
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved another COVID-19 treatment, Xevudy (sotrovimab), after it was found to be safe and effective...
Personalised medication: Why dosage is so important
Rizvan Faruk Batha MPharm, PGDip GPP, IPresc, MRPharmS, Superintendent Pharmacist and Director of Operations at Specialist Pharmacy, examines the benefits of compounded and personalised...
New HIV action plan to end infections by 2030 revealed
The Department of Health and Social Care has revealed a new HIV action plan which aims to reduce new infections by 80% by 2025...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Personalised medication: Why dosage is so important
Rizvan Faruk Batha MPharm, PGDip GPP, IPresc, MRPharmS, Superintendent Pharmacist and Director of Operations at Specialist Pharmacy, examines the benefits of compounded and personalised...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
MHRA approves second monoclonal antibody COVID-19 treatment
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved another COVID-19 treatment, Xevudy (sotrovimab), after it was found to be safe and effective...
MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease
The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Astellas’ Evrenzo™▼ (roxadustat) for the treatment of adult patients with symptomatic anaemia associated with...